ReGen Biologics Inc., established in 1987 and headquartered in Hackensack, New Jersey, specialized in the development, manufacturing, and commercialization of medical devices. These devices were engineered for the restoration and growth of soft human tissues, particularly within orthopedic fields. The company's core asset was its unique collagen matrix technology, which found broader utility across various medical disciplines including general surgery, spinal care, cardiovascular applications, and drug delivery.